Neurodegenerative Disease Management

期刊简介：Neurodegenerative Disease Management presents findings, analysis and commentary in the ongoing battle with this range of debilitating illnesses. The journal provides guidance to the multidisciplinary disease management community regarding the most effective treatment strategies and the implications of cutting-edge research as it emerges. Topics covered include: All neurodegenerative diseases, including Alzheimer’s, Parkinson’s, Huntington’s, ALS and multiple sclerosis Disease mechanisms Epidemiology Genetic and environmental influences on disease pathogenesis Clinical manifestations and diagnosis of disease Use of biomarkers in diagnosis and prognosis Use of technology to track symptoms and impact of treatment Therapeutic options Evaluation and management of cognitive impairment and dementia Prospects for new treatments such as cell and gene therapy Medical treatment guidelines Adverse events and drug safety Pharmacoeconomics, outcomes research, real-world evidence and quality of life Disease management in developed and developing countries Palliative care Articles are subject to peer review by three independent referees on a double-blind basis. Authors publishing in the journal are asked to disclose any professional or financial interest that may be perceived as causing a conflict of interest in the context of the article. The journal welcomes unsolicited article proposals.

【译文】《神经退行性疾病管理》介绍了与这一系列使人衰弱的疾病的持续斗争中的发现、分析和评论。该杂志为多学科疾病管理界提供有关最有效的治疗策略和前沿研究的影响的指导。涵盖的主题包括： 所有神经退行性疾病，包括阿尔茨海默病、帕金森病、亨廷顿病、ALS 和多发性硬化症 疾病机制 流行病学 遗传和环境对疾病发病机制的影响 疾病的临床表现和诊断 使用生物标志物进行诊断和预后 使用技术跟踪症状和治疗影响 治疗选择 认知障碍和痴呆的评估和管理 细胞和基因治疗等新疗法的前景 医疗指南 不良事件和药物安全药物经济学、结果研究、现实世界证据和生活质量发达国家和发展中国家的疾病管理姑息治疗文章由三名独立审稿人在双盲的基础上进行同行评审。在期刊上发表文章的作者被要求披露任何可能被视为导致文章背景下的利益冲突的专业或经济利益。该期刊欢迎主动提出的文章提案。